Aardvark Therapeutics Competitors and Similar CompaniesClear all

Aardvark Therapeutics's competitors and similar companies include AptamiR Therapeutics and UCB.

	Aardvark Therapeutics Aardvark Therapeutics is a company that specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.	AptamiR Therapeutics AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 2017	Founding Date 2012	Founding Date 1928
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech therapy	Tags Healthcare biotech drug development pharma
Locations	Locations San Diego, US HQ San Diego, US	Locations Austin, US HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 18	Employees N/A	Employees 9,052
Financial
Net income	Net income ($57.6m) (FY, 2025)	Net income N/A	Net income €1.6b (FY, 2025)

For sources of this data, please see the company profile

Austin, US

AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders.

Brussels, BE

Employees

9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

Financial